The Celsis Advance II instrument provides a high-throughput ATP bioluminescence rapid microbiology detection solution that has helped companies worldwide screen products for microbial contamination. It offers an exceptionally high throughput of up to 120 assays per hour, supporting large-scale manufacturing operations by delivering results in less than 48 hours for microbial limits USP (<61>) and 6 days for sterility testing (USP <71>).

• Amplified ATP Bioluminescence
• 120 samples per hour
• Application: Microbial contamination testing for sterility, in-process, bioburden, and microbial limits. Preserves standard sample preparation methods for both membrane filtration and direct inoculation. Compatible with standard pharmaceutical APIs, biologics, vaccines, cellular and gene therapy products, ATMPs, opaque, viscous, and complex product formulations.
• FDA 21 CFR Part 11, EU Annex 11, FDA Drug Master File on Record